Question · asked by 1 review
Hormonal therapy vs placebo or no intervention: Effect on later sexual function
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Hormonal therapy vs placebo or no intervention SERMs + estrogen Sexual function score measured by MENQoL sexual subscore (higher score = better sexual functioning) · unselected postmenopausal womena Hormone therapy for sexual function in perimenopausal and postmenopausal women (2023) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 272 participants | Very low |
Hormonal therapy vs placebo or no intervention Estrogen alone Sexual function score measured by FSFI (higher score = better sexual functioning); WHQ sexual subscore (higher score = better sexual functioning); MENQoL sexual subscore (higher score = better sexual functioning) · unselected postmenopausal womena Hormone therapy for sexual function in perimenopausal and postmenopausal women (2023) · Cochrane Headline outcomes only | no estimate extracted | 6 studies · 608 participants | Moderate |
Hormonal therapy vs placebo or no intervention Estrogen + progestogens Sexual function score measured by WHQ sexual subscore (higher score = better sexual functioning) · unselected postmenopausal womena Hormone therapy for sexual function in perimenopausal and postmenopausal women (2023) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 104 participants | Very low |
Hormonal therapy vs placebo or no intervention Synthetic steroids Sexual function score measured by FSFI; WHQ sexual subscore (higher score = better sexual functioning) · unselected postmenopausal womena Hormone therapy for sexual function in perimenopausal and postmenopausal women (2023) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 105 participants | Very low |
Hormonal therapy vs placebo or no intervention SERMs Sexual function score measured by FSFI (higher score = better sexual functioning) · unselected postmenopausal womena Hormone therapy for sexual function in perimenopausal and postmenopausal women (2023) · Cochrane Headline outcomes only | no estimate extracted | 2 studies · 1525 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Hormone therapy for sexual function in perimenopausal and postmenopausal women 2023 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.